Update on polymyalgia rheumatica

European Journal of Internal Medicine

Volumn 24, Issue 7, 2013, Pages 583-589

  Pipitone, Nicolò ^a   Salvarani, Carlo ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Bursitis; Elderly; Glucocorticoids; Polymyalgia rheumatica; TNF inhibitors; Tocilizumab

Indexed keywords

ETANERCEPT; GLUCOCORTICOID; HLA DRB1 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; METHOTREXATE; PREDNISONE; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA;

DISEASE PREDISPOSITION; GENE CLUSTER; GENETIC POLYMORPHISM; GENOTYPE; GIANT CELL ARTERITIS; HUMAN; LABORATORY TEST; MAJOR HISTOCOMPATIBILITY COMPLEX; MORBIDITY; MORTALITY; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PROMOTER REGION; REVIEW; RHEUMATIC POLYMYALGIA; T LYMPHOCYTE;

BURSITIS; ELDERLY; GLUCOCORTICOIDS; POLYMYALGIA RHEUMATICA; TNF-Α INHIBITORS; TOCILIZUMAB;

ANTIRHEUMATIC AGENTS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; GLUCOCORTICOIDS; HUMANS; POLYMYALGIA RHEUMATICA; RECURRENCE;

EID: 84884283485     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.03.003     Document Type: Review

References (78)

1. L. Alvarez-Rodriguez, E. Carrasco-Marin, M. Lopez-Hoyos, C. Mata, L. Fernandez-Prieto, M. Ruiz-Soto, and J. Calvo Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: association of IL-1RN*2/2 genotype with polymyalgia rheumatica Hum Immunol 70 2009 49 54
2. M.M. Amoli, E. Shelley, D.L. Mattey, C. Garcia-Porrua, W. Thomson, and A.H. Hajeer Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica J Rheumatol 29 2002 502 504
3. H.S. Barber Myalgic syndrome with constitutional effects: polymyalgia rheumatica Ann Rheum Dis 16 1957 230 237
4. H.A. Bird, W. Esselinckx, A.S. Dixon, A.G. Mowat, and P.H. Wood An evaluation of criteria for polymyalgia rheumatica Ann Rheum Dis 38 1979 434 439
5. D. Blockmans, L. De Ceuninck, S. Vanderschueren, D. Knockaert, L. Mortelmans, and H. Bobbaers Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients Rheumatology (Oxford) 46 2007 672 677
6. P. Boesen, and S.F. Sorensen Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985 Arthritis Rheum 30 1987 294 299
7. L. Boiardi, B. Casali, E. Farnetti, N. Pipitone, D. Nicoli, and F. Cantini Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica J Rheumatol 33 2006 703 708
8. W. Bruce Senile rheumatic gout BMJ 2 1888 811 813
9. D. Camellino, and M.A. Cimmino Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis Rheumatology (Oxford) 51 2011 77 86
10. F. Cantini, C. Salvarani, I. Olivieri, L. Barozzi, L. Macchioni, and L. Niccoli Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study Ann Rheum Dis 58 1999 230 236
11. F. Cantini, C. Salvarani, I. Olivieri, L. Niccoli, P. Macchioni, and L. Boiardi Inflamed shoulder structures in polymyalgia rheumatica with normal erythrocyte sedimentation rate Arthritis Rheum 44 2001 1155 1159
12. F. Cantini, C. Salvarani, I. Olivieri, L. Niccoli, A. Padula, and L. Macchioni Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study J Rheumatol 28 2001 1049 1055
13. R. Caporali, M.A. Cimmino, G. Ferraccioli, R. Gerli, C. Klersy, C. Salvarani, and C. Montecucco Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial Ann Intern Med 141 2004 493 500
14. M.G. Catanoso, P. Macchioni, L. Boiardi, N. Pipitone, and C. Salvarani Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study Arthritis Rheum 57 2007 1514 1519
15. D. Christidis, S. Jain, and G.B. Das Successful use of tocilizumab in polymyalgic onset biopsy positive GCA with large vessel involvement BMJ Case Rep 2011 2011
16. T.Y. Chuang, G.G. Hunder, D.M. Ilstrup, and L.T. Kurland Polymyalgia rheumatica: a 10-year epidemiologic and clinical study Ann Intern Med 97 1982 672 680
17. B. Dasgupta, F.A. Borg, N. Hassan, K. Barraclough, B. Bourke, and J. Fulcher BSR and BHPR guidelines for the management of polymyalgia rheumatica Rheumatology (Oxford) 49 2010 186 190
18. B. Dasgupta, M.A. Cimmino, H. Maradit-Kremers, W.A. Schmidt, M. Schirmer, and C. Salvarani 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative Ann Rheum Dis 71 2012 484 492
19. B. Dasgupta, and G.S. Panayi Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis Br J Rheumatol 29 1990 456 458
20. C.L. Deal, R.F. Meenan, D.L. Goldenberg, J.J. Anderson, B. Sack, R.S. Pastan, and A.S. Cohen The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration Arthritis Rheum 28 1985 987 994
21. C. Dejaco, C. Duftner, M.A. Cimmino, B. Dasgupta, C. Salvarani, and C.S. Crowson Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus Ann Rheum Dis 70 2011 447 453
22. J. Eshaghian, and J.A. Goeken C-reactive protein in giant cell (cranial, temporal) arteritis Ophthalmology 87 1980 1160 1166
23. B. Frediani, P. Falsetti, L. Storri, S. Bisogno, F. Baldi, and V. Campanella Evidence for synovitis in active polymyalgia rheumatica: sonographic study in a large series of patients J Rheumatol 29 2002 123 130
24. P. Ghosh, F.A. Borg, and B. Dasgupta Current understanding and management of giant cell arteritis and polymyalgia rheumatica Expert Rev Clin Immunol 6 2010 913 928
25. M.A. Gonzalez-Gay Genetic epidemiology. Giant cell arteritis and polymyalgia rheumatica Arthritis Res 3 2001 154 157
26. M.A. Gonzalez-Gay, M.M. Amoli, C. Garcia-Porrua, and W.E. Ollier Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica Semin Arthritis Rheum 33 2003 38 48
27. M.A. Gonzalez-Gay, C. Garcia-Porrua, J.C. Amor-Dorado, and J. Llorca Giant cell arteritis without clinically evident vascular involvement in a defined population Arthritis Rheum 51 2004 274 277
28. M.A. Gonzalez-Gay, C. Garcia-Porrua, and W.E. Ollier Polymyalgia rheumatica and biopsy-proven giant cell arteritis exhibit different HLA-DRB1* associations J Rheumatol 30 2003 2729
29. M.A. Gonzalez-Gay, C. Garcia-Porrua, C. Salvarani, I. Olivieri, and G.G. Hunder The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain J Rheumatol 27 2000 2179 2184
30. M.A. Gonzalez-Gay, A.H. Hajeer, A. Dababneh, C. Garcia-Porrua, D.L. Mattey, M.M. Amoli, W. Thomson, and W.E. Ollier IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis Clin Exp Rheumatol 20 2002 179 184
31. M.A. Gonzalez-Gay, T.R. Vazquez-Rodriguez, M.J. Lopez-Diaz, J.A. Miranda-Filloy, C. Gonzalez-Juanatey, J. Martin, and J. Llorca Epidemiology of giant cell arteritis and polymyalgia rheumatica Arthritis Rheum 61 2009 1454 1461
32. K. Hagihara, I. Kawase, T. Tanaka, and T. Kishimoto Tocilizumab ameliorates clinical symptoms in polymyalgia rheumatica J Rheumatol 37 2010 1075 1076
33. B. Hazleman Laboratory investigations useful in the evaluation of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) Clin Exp Rheumatol 18 2000 S29 S31
34. L.A. Healey Long-term follow-up of polymyalgia rheumatica: evidence for synovitis Semin Arthritis Rheum 13 1984 322 328
35. J. Hernandez-Rodriguez, M.C. Cid, A. Lopez-Soto, G. Espigol-Frigole, and X. Bosch Treatment of polymyalgia rheumatica: a systematic review Arch Intern Med 169 2009 1839 1850
36. M. Jimenez-Palop, E. Naredo, L. Humbrado, J. Medina, J. Uson, F. Francisco, M.J. Garcia-Yebenes, and J. Garrido Ultrasonographic monitoring of response to therapy in polymyalgia rheumatica Ann Rheum Dis 69 2010 879 882
37. A. Klauser, F. Frauscher, E.J. Halpern, E. Mur, P. Springer, W. Judmaier, and M. Schirmer Remitting seronegative symmetrical synovitis with pitting edema of the hands: ultrasound, color doppler ultrasound, and magnetic resonance imaging findings Arthritis Rheum 53 2005 226 233
38. F. Kreiner, and H. Galbo Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial Arthritis Res Ther 12 2010 R176
39. V. Kyle, T.E. Cawston, and B.L. Hazleman Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up Ann Rheum Dis 48 1989 667 671
40. V. Kyle, and B.L. Hazleman The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment Ann Rheum Dis 52 1993 847 850
41. B.F. Leeb, and H.A. Bird A disease activity score for polymyalgia rheumatica Ann Rheum Dis 63 2004 1279 1283
42. B.F. Leeb, H.A. Bird, G. Nesher, I. Andel, W. Hueber, and D. Logar EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT) Ann Rheum Dis 62 2003 1189 1194
43. M. Lopez-Hoyos, d.A. Ruiz, R. Blanco, J. Crespo, M. Pena, V. Rodriguez-Valverde, and V.M. Martinez-Taboada Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica Rheumatology (Oxford) 43 2004 655 657
44. I. Lundberg, and E. Hedfors Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis J Rheumatol 17 1990 1340 1345
45. R.F. Makki, S.F. al, M.A. Gonzalez-Gay, C. Garcia-Porrua, W.E. Ollier, and A.H. Hajeer RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis Clin Exp Rheumatol 18 2000 391 393
46. D.L. Mattey, A.H. Hajeer, A. Dababneh, W. Thomson, M.A. Gonzalez-Gay, C. Garcia-Porrua, and W.E. Ollier Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms Arthritis Rheum 43 2000 1749 1755
47. M. Mazzantini, C. Torre, M. Miccoli, A. Baggiani, R. Talarico, S. Bombardieri, and M.O. Di Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study J Rheumatol 39 2012 552 557
48. E.M. McCarthy, P.A. Macmullan, S. Al-Mudhaffer, A. Madigan, S. Donnelly, and C.J. McCarthy Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumatica Rheumatology (Oxford) 52 2013 465 471
49. D.J. McCarty, J.D. O'Duffy, L. Pearson, and J.B. Hunter Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome JAMA 254 1985 2763 2767
50. R. Meliconi, L. Pulsatelli, M. Uguccioni, C. Salvarani, P. Macchioni, and C. Melchiorri Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment Arthritis Rheum 39 1996 1199 1207
51. J.D. O'Duffy, H.W. Wahner, and G.G. Hunder Joint imaging in polymyalgia rheumatica Mayo Clin Proc 51 1976 519 524
52. M.J. Pacheco, J.A. Amado, M. Lopez-Hoyos, R. Blanco, M.T. Garcia-Unzueta, V. Rodriguez-Valverde, and V.M. Martinez-Taboada Hypothalamic-pituitary- adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis Semin Arthritis Rheum 32 2003 266 272
53. J.M. Pego-Reigosa, M. Rodriguez-Rodriguez, Z. Hurtado-Hernandez, J. Gromaz-Martin, D. Taboas-Rodriguez, C. Millan-Cachinero, I. Hernandez-Rodriguez, and M.A. Gonzalez-Gay Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms Arthritis Rheum 53 2005 931 938
54. F. Perfetto, A. Moggi-Pignone, A. Becucci, F. Cantini, N.M. Di, R. Livi, A. Tempestini, and M. Matucci-Cerinic Seasonal pattern in the onset of polymyalgia rheumatica Ann Rheum Dis 64 2005 1662 1663
55. N. Pipitone, B. Hazelman, and C. Salvarani Polymyalgia rheumatica and giant cell arteritis EULAR compendium on rheumatic diseases 2009 BMJ Publishing Group 556 573
56. N. Pipitone, and C. Salvarani The role of infectious agents in the pathogenesis of vasculitis Best Pract Res Clin Rheumatol 22 2008 897 911
57. C.A. Rust, B. Knechtle, T. Rosemann, and F. Wermelinger Polymyalgia rheumatica in a married couple J Gen Intern Med 5 2012 711 714
58. S. Ruta, J. Rosa, D.A. Navarta, C. Saucedo, L.J. Catoggio, R.G. Monaco, and E.R. Soriano Ultrasound assessment of new onset bilateral painful shoulder in patients with polymyalgia rheumatica and rheumatoid arthritis Clin Rheumatol 31 2012 1383 1387
59. C. Salvarani, L. Barozzi, F. Cantini, L. Niccoli, L. Boiardi, M. Valentino, and N. Pipitone Cervical interspinous bursitis in active polymyalgia rheumatica Ann Rheum Dis 67 2008 758 761
60. C. Salvarani, F. Cantini, L. Boiardi, and G.G. Hunder Polymyalgia rheumatica and giant-cell arteritis N Engl J Med 347 2002 261 271
61. C. Salvarani, F. Cantini, L. Boiardi, and G.G. Hunder Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis Clin Exp Rheumatol 21 2003 S23 S28
62. C. Salvarani, F. Cantini, and G.G. Hunder Polymyalgia rheumatica and giant-cell arteritis Lancet 372 2008 234 245
63. C. Salvarani, F. Cantini, P. Macchioni, I. Olivieri, L. Niccoli, A. Padula, and L. Boiardi Distal musculoskeletal manifestations in polymyalgia rheumatica: a prospective followup study Arthritis Rheum 41 1998 1221 1226
64. C. Salvarani, F. Cantini, L. Niccoli, M.G. Catanoso, P. Macchioni, L. Pulsatelli, A. Padula, I. Olivieri, and L. Boiardi Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study J Rheumatol 30 2003 760 763
65. C. Salvarani, F. Cantini, I. Olivieri, L. Barozzi, L. Macchioni, and L. Niccoli Proximal bursitis in active polymyalgia rheumatica Ann Intern Med 127 1997 27 31
66. C. Salvarani, B. Casali, L. Boiardi, A. Ranzi, P. Macchioni, D. Nicoli, E. Farnetti, M. Brini, and I. Portioli Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity J Rheumatol 27 2000 1215 1221
67. C. Salvarani, S.E. Gabriel, W.M. O'Fallon, and G.G. Hunder Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991 Arthritis Rheum 38 1995 369 373
68. C. Salvarani, S.E. Gabriel, W.M. O'Fallon, and G.G. Hunder The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern Ann Intern Med 123 1995 192 194
69. C. Salvarani, P. Macchioni, C. Manzini, G. Paolazzi, A. Trotta, and P. Manganelli Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial Ann Intern Med 146 2007 631 639
70. C. Salvarani, P.L. Macchioni, P.L. Tartoni, F. Rossi, R. Baricchi, and C. Castri Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy Clin Exp Rheumatol 5 1987 205 215
71. J. Schmidt, P. Duhaut, A.M. Bourgeois, V. Salle, A. Smail, and D. Chatelain Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study Rheumatology (Oxford) 48 2009 158 159
72. M. Seitz, S. Reichenbach, H.M. Bonel, S. Adler, F. Wermelinger, and P.M. Villiger Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series Swiss Med Wkly 141 2011 w13156
73. J.H. Stone Vasculitis: a collection of pearls and myths Rheum Dis Clin North Am 33 2007 691 739 (v)
74. A. Uddhammar, J. Boman, P. Juto, and D.S. Rantapaa Antibodies against Chlamydia pneumoniae, cytomegalovirus, enteroviruses and respiratory syncytial virus in patients with polymyalgia rheumatica Clin Exp Rheumatol 15 1997 299 302
75. S. Unizony, L. Arias-Urdaneta, E. Miloslavsky, S. Arvikar, A. Khosroshahi, B. Keroack, J. Stone, and J. Stone Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, takayasu arteritis) and polymyalgia rheumatica Arthritis Care Res (Hoboken) 2012
76. M.J. van der Veen, H.J. Dinant, C. Booma-Frankfort, G.A. Albada-Kuipers, and J.W. Bijlsma Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? Ann Rheum Dis 55 1996 218 223
77. C.M. Weyand, and J.J. Goronzy Arterial wall injury in giant cell arteritis Arthritis Rheum 42 1999 844 853
78. C.M. Weyand, K.C. Hicok, G.G. Hunder, and J.J. Goronzy Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis Ann Intern Med 121 1994 484 491